GO:1900227 positive regulation of NLRP3 inflammasome complex assembly: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900227 describes any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly.
• NLRP3 inflammasome assembly is a two-step process requiring a priming signal (e.g., TLR/NF-kB) and an activation signal (e.g., ATP, nigericin, crystals).
• Core components include NLRP3, ASC (PYCARD), and pro-caspase-1, which assemble into a supramolecular complex.
• Positive regulation involves ion flux (K+ efflux, Ca2+), mitochondrial ROS, lysosomal damage, and post-translational modifications.
• Dysregulated NLRP3 inflammasome activation is linked to autoimmune diseases, cancer, and inflammatory disorders.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect positive regulators of NLRP3 assembly.
Description
The NLRP3 inflammasome is a cytosolic multiprotein complex that mediates caspase-1 activation and the maturation of pro-inflammatory cytokines IL-1beta and IL-18. Its assembly is tightly controlled, and excessive activation contributes to a wide range of inflammatory pathologies. GO:1900227, positive regulation of NLRP3 inflammasome complex assembly, refers to any process that activates or increases the frequency, rate or extent of this assembly. Understanding the positive regulators of NLRP3 inflammasome assembly is critical for developing targeted therapies against inflammatory diseases and cancer. This article integrates authoritative GO data and verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, and experimental models used to study this process.
positive regulation of NLRP3 inflammasome complex assembly At A Glance
| GO ID | GO:1900227 |
|---|---|
| GO term | positive regulation of NLRP3 inflammasome complex assembly |
| Ontology | biological_process |
| Synonym | activation of NLRP3 inflammasome complex assembly; upregulation of NLRP3 inflammasome activation |
| Major function | Promotes assembly of the NLRP3 inflammasome complex, leading to caspase-1 activation and IL-1beta/IL-18 maturation |
| Related process | NLRP3 inflammasome complex assembly (GO:1900226) |
| Regulatory signals | K+ efflux, Ca2+ signaling, mitochondrial ROS, lysosomal rupture, post-translational modifications |
| Key components | NLRP3, ASC (PYCARD), pro-caspase-1, NEK7 |
| Disease relevance | Autoinflammatory diseases, autoimmune diseases, cancer, neurodegeneration |
What Is GO:1900227?
GO:1900227 is a biological process term defined as any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly. In other words, it encompasses the molecular events and signals that promote the formation of the NLRP3-ASC-pro-caspase-1 complex, leading to inflammasome activation.
Why Is positive regulation of NLRP3 inflammasome complex assembly Important in Cell Biology?
Positive regulation of NLRP3 inflammasome complex assembly is a central node in innate immunity and inflammation. Dysregulation of this process is implicated in the pathogenesis of autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, as well as in cancer progression and neurodegenerative disorders. Understanding the positive regulators provides opportunities for therapeutic intervention, and CRISPR-based models are indispensable for validating these regulators in physiologically relevant systems.
• Controls innate immune responses to pathogens and danger signals.
• Drives maturation of IL-1beta and IL-18, key pro-inflammatory cytokines.
• Implicated in autoimmune diseases such as rheumatoid arthritis and IBD.
• Plays a dual role in cancer, with context-dependent effects on tumor progression.
• Contributes to neuroinflammation in Alzheimer's and Parkinson's diseases.
• Regulated by ion fluxes, mitochondrial ROS, and lysosomal damage.
• Post-translational modifications (ubiquitination, phosphorylation) fine-tune assembly.
• Target for anti-inflammatory drug development.
• Requires two signals: priming and activation, offering multiple intervention points.
• CRISPR screens can identify novel positive regulators.
What Happens During positive regulation of NLRP3 inflammasome complex assembly?
Priming Signal (Signal 1)
In simple terms: First, the cell gets a warning that activates the NLRP3 gene and prepares the protein.
The priming step involves activation of NF-kB downstream of pattern recognition receptors (e.g., TLR4), leading to increased transcription of NLRP3 and pro-IL-1beta. This step also induces post-translational modifications of NLRP3 that keep it in an autoinhibited state until a second signal arrives.
Activation Signal (Signal 2)
In simple terms: A second danger signal triggers the assembly of the inflammasome complex.
Activation signals include extracellular ATP, nigericin, particulate matter (e.g., uric acid crystals), and lysosomal damage. These signals cause K+ efflux, Ca2+ mobilization, mitochondrial ROS production, and lysosomal rupture, which collectively promote NLRP3 oligomerization and ASC speck formation.
NLRP3 Oligomerization and ASC Recruitment
In simple terms: NLRP3 proteins cluster together and recruit the adaptor ASC to form a platform.
Upon activation, NLRP3 undergoes conformational changes and oligomerizes via its NACHT domain. NEK7 kinase is required for NLRP3 oligomerization and inflammasome assembly. NLRP3 then recruits ASC through PYD-PYD interactions, leading to ASC fibril formation and speck assembly.
Caspase-1 Activation and Cytokine Maturation
In simple terms: The assembled inflammasome activates caspase-1, which cuts pro-IL-1beta and pro-IL-18 into their active forms.
ASC recruits pro-caspase-1 via CARD-CARD interactions, inducing caspase-1 autoproteolysis and activation. Active caspase-1 cleaves pro-IL-1beta and pro-IL-18, and also cleaves gasdermin D to induce pyroptosis.
Regulation by Post-Translational Modifications
In simple terms: Chemical tags on NLRP3 can either promote or inhibit its assembly.
Ubiquitination, phosphorylation, and SUMOylation regulate NLRP3 inflammasome assembly. For example, deubiquitination of NLRP3 by BRCC3 promotes assembly, while ubiquitination by E3 ligases such as TRIM31 inhibits it. Phosphorylation by JNK1 and dephosphorylation by PP2A also modulate assembly.
Key Genes Involved in GO:1900227 positive regulation of NLRP3 inflammasome complex assembly
The following genes and proteins are central to the positive regulation of NLRP3 inflammasome complex assembly.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP3 | Core sensor and scaffold of the inflammasome | Mutations cause cryopyrin-associated periodic syndromes; target for anti-inflammatory drugs |
| PYCARD (ASC) | Adaptor protein linking NLRP3 to caspase-1 | Essential for inflammasome assembly; forms specks |
| CASP1 | Effector protease that matures IL-1beta/IL-18 | Central to inflammasome output; knockout blocks cytokine maturation |
| NEK7 | Kinase required for NLRP3 oligomerization | Facilitates NLRP3-NEK7 interaction; knockout impairs assembly |
| BRCC3 | Deubiquitinase that promotes NLRP3 assembly | Positive regulator; inhibition reduces inflammasome activation |
| TRIM31 | E3 ubiquitin ligase that inhibits NLRP3 | Negative regulator; overexpression suppresses assembly |
| ATG16L2 | Inhibits NLRP3 via autophagy | Overexpression reduces inflammasome activation |
| NCF4 | Modulates inflammasome activation in cancer | Loss attenuates colorectal cancer progression |
| IL1B | Pro-inflammatory cytokine processed by caspase-1 | Readout of inflammasome activation |
| IL18 | Pro-inflammatory cytokine processed by caspase-1 | Readout of inflammasome activation |
| GSDMD | Mediates pyroptosis downstream of caspase-1 | Links inflammasome to cell death |
| TLR4 | Priming receptor for NF-kB activation | Provides signal 1 for NLRP3 transcription |
| NFKB1 | Transcription factor for NLRP3 priming | Knockout reduces NLRP3 expression |
| P2RX7 | ATP-gated ion channel mediating K+ efflux | Activation triggers inflammasome assembly |
| TXNIP | Links oxidative stress to NLRP3 activation | Positive regulator under ROS conditions |
| PKM2 | Kinase that promotes NLRP3 assembly | Metabolic regulator of inflammasome |
How Is positive regulation of NLRP3 inflammasome complex assembly Regulated?
Positive regulation of NLRP3 inflammasome assembly is controlled by multiple layers of regulation, including ion fluxes (K+ efflux, Ca2+ signaling), mitochondrial dysfunction and ROS production, lysosomal damage, and post-translational modifications such as ubiquitination, phosphorylation, and SUMOylation. Additionally, autophagy negatively regulates inflammasome assembly by targeting NLRP3 for degradation, as shown for ATG16L2. These regulatory mechanisms provide potential therapeutic targets for modulating inflammasome activity.
positive regulation of NLRP3 inflammasome complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Cryopyrin-associated periodic syndromes (CAPS) | Knock-in of patient mutations in THP-1 cells |
| NLRP3 | Alzheimer's disease | APP/PS1 mouse model with NLRP3 knockout |
| NCF4 | Colorectal cancer | NCF4 knockout in HCT116 cells |
| IL1B | Autoinflammatory fever syndromes | IL1B reporter knock-in in macrophages |
| CASP1 | Inflammatory bowel disease | Casp1 knockout in intestinal organoids |
Autoinflammatory and Autoimmune Diseases
Gain-of-function mutations in NLRP3 cause cryopyrin-associated periodic syndromes (CAPS), characterized by excessive IL-1beta production. Dysregulated NLRP3 inflammasome activation is also implicated in rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus. Targeting positive regulators of inflammasome assembly may offer therapeutic benefits.
Cancer
NLRP3 inflammasome activation has context-dependent roles in cancer. In colorectal cancer, NCF4 attenuates progression by modulating inflammasome activation and immune surveillance. Conversely, chronic inflammation driven by NLRP3 can promote tumorigenesis in some settings. Understanding positive regulators is crucial for developing cancer therapies.
Neurodegenerative Diseases
Neuroinflammation mediated by NLRP3 inflammasome activation contributes to Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Positive regulators of inflammasome assembly are potential targets for neuroprotective strategies.
From positive regulation of NLRP3 inflammasome complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote NLRP3 inflammasome assembly? | CRISPR knockout of gene X in THP-1 or iBMDM cells followed by inflammasome activation assays |
| Does a specific mutation in NLRP3 affect assembly? | Point mutation knock-in of NLRP3 variants in THP-1 cells |
| Does gene X interact with NLRP3? | Tagged knock-in of NLRP3 (e.g., GFP) for co-IP and imaging |
| Does overexpression of gene X enhance inflammasome activation? | Lentiviral overexpression of gene X in macrophages |
| Which genes regulate inflammasome assembly genome-wide? | CRISPR library screening in THP-1 cells with readout of caspase-1 activation |
| Does gene X regulate inflammasome in vivo? | Knockout mouse models with disease challenge (e.g., EAE, colitis) |
How to Study the positive regulation of NLRP3 inflammasome complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Cleaved caspase-1, IL-1beta | Inflammasome activation in cell lysates |
| ELISA | Secreted IL-1beta | Quantification of inflammasome output |
| Immunofluorescence | ASC specks | Visualization of assembly in cells |
| CRISPR knockout screen | Gene requirement for inflammasome activation | Identification of positive regulators |
| AP-MS | Protein-protein interactions | Mapping NLRP3 interactome |
| BioID | Proximity labeling of NLRP3 interactors | Dynamic interactome in live cells |
| RNA-seq | Transcriptional changes | Priming and inflammasome-related gene expression |
Inflammasome Activation Assays
Inflammasome activation is commonly measured by detecting cleaved caspase-1, IL-1beta, and ASC specks using Western blot, ELISA, and immunofluorescence. LPS priming followed by ATP or nigericin stimulation is a standard protocol.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify positive regulators of NLRP3 inflammasome assembly. Readouts include caspase-1 activation, IL-1beta secretion, or ASC speck formation.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify proteins interacting with NLRP3 during assembly. Proximity labeling (BioID) can capture dynamic interactions.
Imaging of ASC Specks
Fluorescence microscopy and live-cell imaging visualize ASC speck formation, a hallmark of inflammasome assembly. Tagged ASC (e.g., GFP-ASC) enables real-time monitoring.
How CRISPR Can Be Used to Study GO:1900227 positive regulation of NLRP3 inflammasome complex assembly
Knockout
CRISPR knockout of candidate positive regulators (e.g., NEK7, BRCC3) in THP-1 or iBMDM cells followed by inflammasome activation assays can validate their requirement for NLRP3 assembly.
Point Mutation
Point mutation knock-in of disease-associated NLRP3 variants (e.g., CAPS mutations) can model gain-of-function effects on inflammasome assembly.
Knock-in
Tagged knock-in of NLRP3 or ASC (e.g., GFP, HA) enables visualization and immunoprecipitation of the inflammasome complex in native conditions.
Overexpression
Overexpression of positive regulators (e.g., BRCC3) or negative regulators (e.g., ATG16L2) can modulate inflammasome assembly and provide mechanistic insights.
How EDITGENE Supports positive regulation of NLRP3 inflammasome complex assembly Research
Researchers studying positive regulation of NLRP3 inflammasome complex assembly-related genes often need to determine whether a candidate gene is causally involved in inflammasome activation or is merely a bystander. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of NLRP3 inflammasome complex assembly research.
Frequently Asked Questions About positive regulation of NLRP3 inflammasome complex assembly
What is GO:1900227?
GO:1900227 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly.
What genes are involved in positive regulation of NLRP3 inflammasome complex assembly?
Key genes include NLRP3, PYCARD (ASC), CASP1, NEK7, BRCC3, TRIM31, ATG16L2, and NCF4.
How is NLRP3 inflammasome assembly activated?
It requires a priming signal (e.g., LPS via NF-kB) and an activation signal (e.g., ATP, nigericin) that triggers K+ efflux, ROS, and lysosomal damage.
What diseases are associated with NLRP3 inflammasome dysregulation?
Autoinflammatory diseases (CAPS), autoimmune diseases, cancer, and neurodegenerative diseases.
What is the role of NEK7 in NLRP3 inflammasome assembly?
NEK7 is a kinase required for NLRP3 oligomerization and inflammasome assembly.
How can CRISPR be used to study NLRP3 inflammasome assembly?
CRISPR knockout, knock-in, and overexpression models can validate the role of specific genes in inflammasome assembly.
What are the two signals required for NLRP3 inflammasome activation?
Signal 1 is priming (e.g., TLR/NF-kB), and Signal 2 is activation (e.g., ATP, nigericin).
What is the role of ASC in NLRP3 inflammasome assembly?
ASC (PYCARD) is an adaptor protein that links NLRP3 to caspase-1 and forms specks.
How is NLRP3 inflammasome assembly regulated by ubiquitination?
Ubiquitination and deubiquitination of NLRP3 modulate assembly; BRCC3 promotes it, while TRIM31 inhibits it.
What experimental models are used to study positive regulation of NLRP3 inflammasome assembly?
THP-1 cells, iBMDMs, and knockout mouse models are commonly used, along with CRISPR screens.
Conclusion
GO:1900227, positive regulation of NLRP3 inflammasome complex assembly, is a critical biological process in innate immunity and inflammation. Its dysregulation contributes to a variety of human diseases, making it an attractive therapeutic target. Advances in CRISPR-based models and screening technologies are accelerating the discovery of positive regulators and their mechanisms. EDITGENE offers comprehensive services to support research in this field, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Paik S et al.. 2021. An update on the regulatory mechanisms of NLRP3 inflammasome activation.. Cell Mol Immunol 18(5):1141-1160 PMID: 33850310
- 2. Paik S et al.. 2025. Updated insights into the molecular networks for NLRP3 inflammasome activation.. Cell Mol Immunol 22(6):563-596 PMID: 40307577
- 3. Li L et al.. 2024. NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance.. Nat Commun 15(1):5170 PMID: 38886341
- 4. Ren W et al.. 2024. NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target.. Biomed Pharmacother 175:116679 PMID: 38701567
- 5. Wang D et al.. 2022. ATG16L2 inhibits NLRP3 inflammasome activation through promoting ATG5-12-16L1 complex assembly and autophagy.. Eur J Immunol 52(8):1321-1334 PMID: 35426127
- 6. Krantz M et al.. 2023. A detailed molecular network map and model of the NLRP3 inflammasome.. Front Immunol 14:1233680 PMID: 38077364
- 7. Mariathasan S et al.. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP.. Nature 440(7081):228-32 PMID: 16407890
- 8. Beesetti S. 2025. Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation.. Front Biosci (Landmark Ed) 30(3):25970 PMID: 40152367
